Sunder Mudaliar

Sunder Mudaliar

University of California San Diego - San Diego / United States
Others
AD Scientific Index ID: 1771774
person_outline Sunder Mudaliar's MOST POPULAR ARTICLES
1-) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trialHC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...The Lancet 394 (10193), 121-130, 201916122019
2-) Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitroJW Kolaczynski, MR Nyce, RV Considine, G Boden, JJ Nolan, R Henry, ...Diabetes 45 (5), 699-701, 199611321996
3-) Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver diseaseS Mudaliar, RR Henry, AJ Sanyal, L Morrow, HU Marschall, M Kipnes, ...Gastroenterology 145 (3), 574-582. e1, 20139062013
4-) Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFL Greenway, K Fujioka, RA Plodkowski, S Mudaliar, M Guttadauria, ...The Lancet 376 (9741), 595-605, 201010682010
5-) Pioglitazone for diabetes prevention in impaired glucose toleranceRA DeFronzo, D Tripathy, DC Schwenke, MA Banerji, GA Bray, ...New England Journal of Medicine 364 (12), 1104-1115, 20119402011